Deadline to Join Class Action Lawsuit Against Novo Nordisk A/S (NVO) is September 30, 2025

The deadline to join a class-action lawsuit against Novo Nordisk A/S (NVO) is approaching on September 30, 2025. Levi & Korsinsky is handling the case and is inviting eligible participants to come forward. This lawsuit stems from allegations of misleading statements and potential violations of federal securities laws by Novo Nordisk A/S.

The lawsuit claims that Novo Nordisk A/S made misleading statements and failed to disclose material information regarding their business operations, financial performance, and prospects. The company’s actions allegedly caused its stock prices to be artificially inflated during the relevant period.

Investors who purchased shares of Novo Nordisk A/S between February 5, 2020, and August 3, 2025, may be eligible to join the class-action lawsuit. Those who wish to participate must do so before the September 30, 2025 deadline. The lawsuit aims to recover damages on behalf of investors who suffered losses due to the alleged misconduct of Novo Nordisk A/S.

Levi & Korsinsky is a national firm with extensive experience in securities litigation. They have a track record of representing investors in high-stakes cases against companies accused of securities fraud. The firm is committed to holding corporations accountable for misleading investors and violating securities laws.

If you believe you have been affected by Novo Nordisk A/S’s alleged misconduct, now is the time to take action. By joining the class-action lawsuit, you may have the opportunity to recover financial losses incurred as a result of the company’s actions. Contact Levi & Korsinsky before the September 30, 2025, deadline to learn more about your options and eligibility to participate in the lawsuit.

This class-action lawsuit highlights the importance of transparency and accountability in the financial markets. Investors rely on accurate and timely information to make informed decisions about their investments. When companies fail to disclose material information or make misleading statements, investors can suffer significant financial losses.

The deadline to join the class-action lawsuit against Novo Nordisk A/S is quickly approaching. Investors who purchased shares of the company between February 5, 2020, and August 3, 2025, are encouraged to contact Levi & Korsinsky before the September 30, 2025 deadline. Take action now to protect your rights and seek recovery for any losses you may have suffered due to Novo Nordisk A/S’s alleged misconduct.